WHO identifies Ebola treatments, urgesvaccines be tested in trials
Japan Today [Unofficial]
May 28, 2026
The World Health Organization recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola, including Mapp Biopharmaceutical's MBP134, Regeneron's maftivimab and Gilead Sciences' antiviral remdesivir.
The WHO…
Discussion in the ATmosphere